USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TRANSTIMULATION RESEARCH, INC.
Address:
921 NE 13TH ST (VRF/151)
OKLAHOMA CITY, OK 73104-5007
Phone:
N/A
URL:
N/A
EIN:
156252394
DUNS:
602492642
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,250,330.00 6
SBIR Phase II $652,500.00 1

Award List:

THERAPEUTIC POTENTIAL OF INTESTINAL PACING FOR OBESITY

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The prevalence of obesity is rising to epidemic proportions around the world at an alarming rate. Obesity is a serious medical problem: in the United States, it is estimated that about 300,000 deaths are caused by obesity every year; more than $100 billion is… More

Dual-pulse electrical stimulation for gastroparesis

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$250,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Gastroparesis is a common disease defined as the delayed emptying of the stomach. It is present in at least 20% of about 150 million patients with diabetes worldwide and in more than 20% of patients with functional dyspepsia that affects about 10-25% of the… More

THERAPEUTIC POTENTIAL OF INTESTINAL PACING FOR OBESITY

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$652,500.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Obesity is a serious medical problem: in the United States alone, it causes approximately 300,000 deaths and estimated healthcare costs in the amount of $100 billion per year. However, currently available therapy remains unsatisfactory. In this project, we… More

Intestinal Pacing for Intestinal Pseudo-Obstruction

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Chronic idiopathic intestinal pseudo-obstruction (CIP) is a life-threatening disease without a cure. Severe postoperative ileus is common in patients after abdominal surgery and requires extensive hospitalization. Both diseases are characterized with delayed… More

Neurogastric electrical stimulation for treating chemotherapy-induced emesis

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. Over one million people get cancer each year. Approximately one out of every two American men and one out of every three A merican women will have some type of cancer… More

Transcutaneous electroacupuncture for gastroparesis

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Gastroparesis is a common disease defined as delayed emptying of the stomach. It is present in at least 20% of about 150 million patients with diabetes worldwide and in more than 20% of patients with functional dyspeps ia that affects about 10%-25% of the… More

Expanding Precision Particle Fabrication Technology for the Widespread Control of

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$200,330.00
Agency:
HHS
Principal Investigator:
Jiande Chen – 409-747-3071
Abstract:
DESCRIPTION (provided by applicant): Diabetes affects more than 8% of Americans and costs over 174 billion in 2007 in USA. Recently bariatric surgery, such as Roux-en-Y gastric bypass, has been proposed for treating diabetic patients with obesity due to its hypoglycemic effect on postprandial blood… More